Global Neurovascular Devices Market Size, Share, and Industry Analysis – by Product Type, by Application, and by End-use – Growth and Trend Forecast, 2026-2035

The global neurovascular devices market was estimated to be worth USD 7.7 billion in 2025. The market is expected to grow at a CAGR of 5.8% from USD 8.1 billion in 2026 to USD 13.5 billion by 2035. The strong market growth is driven by the rising prevalence of chronic diseases, ageing populations, and technological advancements and innovations.

Published: March 2, 2026
100 Pages

Market Overview

According to the Centers for Disease Control and Prevention, about 795,000 individuals in the US have a stroke annually, resulting in one of the leading causes of death in the country. Additionally, according to the American Heart Association, stroke is responsible for one out of every six cardiovascular fatalities, underscoring the significant clinical burden that fuels the market for neurovascular devices. Further supporting the increasing use of thrombectomy devices, stent retrievers, and embolisation technologies in U.S. hospitals is data from the National Institute of Neurological Disorders and Stroke, which shows that ischaemic strokes make up about 87% of all stroke cases.

The global neurovascular devices market has experienced significant growth over the past decade, mainly driven by increasing rates of aneurysms and strokes and advances in endovascular technologies. Additionally, product innovation and the wider adoption of minimally invasive neurointerventions supported growth from 2020 to 2022. For example, according to a 2022 Penumbra, Inc. announcement, the launch of RED® Reperfusion Catheters in Europe enhanced acute ischaemic stroke treatments.

The anticipated growth of the neurovascular devices market is propelled by the increasing prevalence of diseases, ageing demographics, and a growing focus on early diagnosis. The growth is further supported in emerging economies by expanding the infrastructure for stroke care. For instance, according to Medtronic’s forecast outlook, the ongoing development of its neurovascular portfolio is anticipated to sustain market expansion through 2032, driven by increased adoption globally and better clinical results.

Neurovascular Devices Market Overview

Base Year Market Size (2025): USD 7.7 Billion

CAGR: 5.8%

Forecast Year Market Size (2035): USD 13.5 Billion

Leading Region: North America

Emerging Countries: China, India, Brazil, Mexico, UAE

Major Players:

· Medtronic plc

· Stryker Corporation

· Johnson & Johnson (Cerenovus)

· Penumbra, Inc.

· Terumo Corporation

Neurovascular Devices Market Trends

  • The global neurovascular devices market is undergoing a transformative phase, propelled by developments in thrombectomy and flow diversion systems, improved imaging integration, and minimally invasive endovascular technology.

  • Growing inclination towards catheter-based neurointerventional techniques rather than surgical surgery due to shorter recovery periods, fewer complications, and improved patient outcomes.

  • The development of organized care paths and specialized comprehensive stroke centres, and expanding access to neurointerventional therapies, especially in developing nations.

  • Furthermore, integrating digital treatment planning and high-resolution imaging improves procedural accuracy and enables individualised neurovascular therapy.

  • Additionally, AI-powered decision-support tools, workflow optimization, and image analysis are increasingly being adopted to increase the effectiveness of neurovascular therapies by improving clinical outcomes, procedural planning, and stroke detection speed.

Collectively, these trends are expected to accelerate market expansion, drive technological innovation, and strengthen the global adoption of neurovascular devices across advanced and emerging healthcare systems in the coming years.

Neurovascular Devices Market Analysis

By Product Type

Neurovascular thrombectomy devices continue to be essential for treating acute ischaemic stroke, driven by their significant adoption support from guidelines and their life-saving clinical impact.

Based on product type, the global neurovascular devices market is segmented into neurovascular thrombectomy devices, neurovascular embolization devices, neurovascular stents, and neurovascular balloons. The neurovascular thrombectomy devices segment dominated the market, accounting for 42.46% market share. This segment is further categorized into rheolytic devices, aspiration catheters, combined thrombectomy systems, and stent retrievers.

By Application

Acute ischemic stroke drives the highest demand for neurovascular devices, fueled by growing procedural volumes and urgent intervention needs.

Based on application, the global neurovascular devices market is categorized into acute ischemic stroke, hemorrhagic stroke, intracranial aneurysm, arteriovenous malformations (AVMs) & AV fistulas, carotid artery disease, and others. The acute ischemic stroke segment held a large market share in 2025.

By End-use

Hospitals continue to be the main end-users of neurovascular devices, due to high procedural volumes, specialized stroke care units, and advanced interventional infrastructure.

Based on the end-use, the global neurovascular devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment accounted for the largest market share in 2025 and is expected to expand at a significant CAGR over the forecast period.

Regional Analysis

North America drives the neurovascular devices market with robust R&D investment and extensive use of minimally invasive procedures

North America held the largest share of 41.92% in the global neurovascular devices market.

Europe emerges as a steadily growing neurovascular devices market, supported by regulatory clarity and rising stroke intervention adoption

Increasing stroke rates and growing neuro-interventional initiatives in nations like the UK, France, and Germany are driving demand for devices.

Key Companies Profiled

The competitive landscape of the global neurovascular devices market is characterised by intense competition between innovative medical technology companies and prominent global companies. Leading companies, including Terumo Corporation, Penumbra, Johnson & Johnson (Cerenovus), Stryker, and Medtronic, together possess majority of the global market share, supported by their robust global distribution networks and extensive neurovascular portfolios. While other major players in the market are expanding geographically, especially in emerging regions, through product launches, regulatory approvals, and strategic alliances.

Additionally, the market is witnessing the gradual adoption of regional manufacturers and specialized device manufacturers, offering affordable neurovascular solutions, particularly in Asia-Pacific and Latin America. Furthermore, a greater emphasis on next-generation device design, minimally invasive stroke treatment, and better clinical results is increasing competition, compelling companies to improve treatment success rates, safety, and procedural efficiency.

Neurovascular Devices Market Companies:

The following prominent companies are driving innovation and expansion in the global neurovascular devices market:

· Abbott Laboratories

· Acandis GmbH

· ASAHI INTECC Co., Ltd.

· Balt Group

· B. Braun SE

· Boston Scientific Corporation

· Integer Holdings Corporation

· Johnson & Johnson (Cerenovus)

· Kaneka Corporation

· Medtronic plc

· MicroPort Scientific Corporation

· MicroVention, Inc. (Terumo Group)

· Penumbra, Inc.

· Perflow Medical Ltd.

· Rapid Medical

· Stryker Corporation

· Terumo Corporation

Market Segmentation

This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the neurovascular devices market by-

Product Type (Revenue in USD Million, 2021 - 2035)

  • Neurovascular Thrombectomy Devices

    • Stent Retrievers

    • Aspiration Catheters

    • Combined Thrombectomy Systems

    • Rheolytic Devices

  • Neurovascular Embolization Devices

    • Embolization Coils

    • Flow Diversion Devices

    • Liquid Embolic Agents

    • Particles & Microspheres

  • Neurovascular Stents

    • Carotid Artery Stents

    • Intracranial Stents

  • Neurovascular Balloons

    • Compliant Balloons

    • Non-Compliant Balloons

    • Semi-Compliant Balloons

Application (Revenue in USD Million, 2021 - 2035)

  • Acute Ischemic Stroke

  • Hemorrhagic Stroke

  • Intracranial Aneurysm

  • Arteriovenous Malformations (AVMs) & AV Fistulas

  • Carotid Artery Disease

  • Others

End-use (Revenue in USD Million, 2021 – 2035)

  • Hospitals

  • Specialty Clinics

  • Others

Regional (Revenue in USD Million, 2021 - 2035)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

    • Switzerland

    • Netherlands

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

    • Indonesia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2024 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Consumer Behaviour Analysis

3.5. Value Chain Analysis

3.6. Technology Roadmap

3.7. Porters Analysis

3.8. PESTLE Analysis

4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)

4.1. Neurovascular Thrombectomy Devices

4.1.1. Stent Retrievers

4.1.2. Aspiration Catheters

4.1.3. Combined Thrombectomy Systems

4.1.4. Rheolytic Devices

4.2. Neurovascular Embolization Devices

4.2.1. Embolization Coils

4.2.2. Flow Diversion Devices

4.2.3. Liquid Embolic Agents

4.2.4. Particles & Microspheres

4.3. Neurovascular Stents

4.3.1. Carotid Artery Stents

4.3.2. Intracranial Stents

4.4. Neurovascular Balloons

4.4.1. Compliant Balloons

4.4.2. Non-Compliant Balloons

4.4.3. Semi-Compliant Balloons

5. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)

5.1. Acute Ischemic Stroke

5.2. Hemorrhagic Stroke

5.3. Intracranial Aneurysm

5.4. Arteriovenous Malformations (AVMs) & AV Fistulas

5.5. Carotid Artery Disease

5.6. Others

6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)

6.1. Hospitals

6.2. Specialty Clinics

6.3. Others

7. Market Estimates and Forecasts, By Region, 2021 - 2035 (USD Mn)

7.1. North America

7.1.1. U.S.

7.1.1.1. U.S. Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.1.1.2. Market Dynamics

7.1.1.3. Competitive Landscape

7.1.1.4. Regulatory Framework

7.1.1.5. Reimbursement Scenario

7.1.2. Canada

7.1.2.1. Canada Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.1.2.2. Market Dynamics

7.1.2.3. Competitive Landscape

7.1.2.4. Regulatory Framework

7.1.2.5. Reimbursement Scenario

7.2. Europe

7.2.1. Germany

7.2.1.1. Germany Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.1.2. Market Dynamics

7.2.1.3. Competitive Landscape

7.2.1.4. Regulatory Framework

7.2.1.5. Reimbursement Scenario

7.2.2.

7.2.3. U.K.

7.2.3.1. UK Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.3.2. Market Dynamics

7.2.3.3. Competitive Landscape

7.2.3.4. Regulatory Framework

7.2.3.5. Reimbursement Scenario

7.2.4. France

7.2.4.1. France Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.4.2. Market Dynamics

7.2.4.3. Competitive Landscape

7.2.4.4. Regulatory Framework

7.2.4.5. Reimbursement Scenario

7.2.5. Italy

7.2.5.1. Italy Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.5.2. Market Dynamics

7.2.5.3. Competitive Landscape

7.2.5.4. Regulatory Framework

7.2.5.5. Reimbursement Scenario

7.2.6. Spain

7.2.6.1. Spain Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.6.2. Market Dynamics

7.2.6.3. Competitive Landscape

7.2.6.4. Regulatory Framework

7.2.6.5. Reimbursement Scenario

7.2.7. Sweden

7.2.7.1. Sweden Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.7.2. Market Dynamics

7.2.7.3. Competitive Landscape

7.2.7.4. Regulatory Framework

7.2.7.5. Reimbursement Scenario

7.2.8. Norway

7.2.8.1. Norway Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.8.2. Market Dynamics

7.2.8.3. Competitive Landscape

7.2.8.4. Regulatory Framework

7.2.8.5. Reimbursement Scenario

7.2.9. Denmark

7.2.9.1. Denmark Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.9.2. Market Dynamics

7.2.9.3. Competitive Landscape

7.2.9.4. Regulatory Framework

7.2.9.5. Reimbursement Scenario

7.2.10. Switzerland

7.2.10.1. Switzerland Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.10.2. Market Dynamics

7.2.10.3. Competitive Landscape

7.2.10.4. Regulatory Framework

7.2.10.5. Reimbursement Scenario

7.2.11. Netherlands

7.2.11.1. Netherlands Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.11.2. Market Dynamics

7.2.11.3. Competitive Landscape

7.2.11.4. Regulatory Framework

7.2.11.5. Reimbursement Scenario

7.2.12. Rest of Europe

7.2.12.1. Rest of Europe Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.12.2. Market Dynamics

7.2.12.3. Competitive Landscape

7.2.12.4. Regulatory Framework

7.2.12.5. Reimbursement Scenario

7.3. Asia Pacific

7.3.1. China

7.3.1.1. China Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.1.2. Market Dynamics

7.3.1.3. Competitive Landscape

7.3.1.4. Regulatory Framework

7.3.1.5. Reimbursement Scenario

7.3.2. Japan

7.3.2.1. Japan Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.2.2. Market Dynamics

7.3.2.3. Competitive Landscape

7.3.2.4. Regulatory Framework

7.3.2.5. Reimbursement Scenario

7.3.3. India

7.3.3.1. India Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.3.2. Market Dynamics

7.3.3.3. Competitive Landscape

7.3.3.4. Regulatory Framework

7.3.3.5. Reimbursement Scenario

7.3.4. Australia

7.3.4.1. Australia Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.4.2. Market Dynamics

7.3.4.3. Competitive Landscape

7.3.4.4. Regulatory Framework

7.3.4.5. Reimbursement Scenario

7.3.5. South Korea

7.3.5.1. South Korea Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.5.2. Market Dynamics

7.3.5.3. Competitive Landscape

7.3.5.4. Regulatory Framework

7.3.5.5. Reimbursement Scenario

7.3.6. Thailand

7.3.6.1. Thailand Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.6.2. Market Dynamics

7.3.6.3. Competitive Landscape

7.3.6.4. Regulatory Framework

7.3.6.5. Reimbursement Scenario

7.3.7. Indonesia

7.3.7.1. Indonesia Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.7.2. Market Dynamics

7.3.7.3. Competitive Landscape

7.3.7.4. Regulatory Framework

7.3.7.5. Reimbursement Scenario

7.3.8. Rest of Asia Pacific

7.3.8.1. Rest of Asia Pacific Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.8.2. Market Dynamics

7.3.8.3. Competitive Landscape

7.3.8.4. Regulatory Framework

7.3.8.5. Reimbursement Scenario

7.4. Latin America

7.4.1. Brazil

7.4.1.1. Brazil Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.1.2. Market Dynamics

7.4.1.3. Competitive Landscape

7.4.1.4. Regulatory Framework

7.4.1.5. Reimbursement Scenario

7.4.2. Mexico

7.4.2.1. Mexico Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.2.2. Market Dynamics

7.4.2.3. Competitive Landscape

7.4.2.4. Regulatory Framework

7.4.2.5. Reimbursement Scenario

7.4.3. Argentina

7.4.3.1. Argentina Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.3.2. Market Dynamics

7.4.3.3. Competitive Landscape

7.4.3.4. Regulatory Framework

7.4.3.5. Reimbursement Scenario

7.4.4. Colombia

7.4.4.1. Colombia Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.4.2. Market Dynamics

7.4.4.3. Competitive Landscape

7.4.4.4. Regulatory Framework

7.4.4.5. Reimbursement Scenario

7.5. Middle East and Africa

7.5.1. South Africa

7.5.1.1. South Africa Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.1.2. Market Dynamics

7.5.1.3. Competitive Landscape

7.5.1.4. Regulatory Framework

7.5.1.5. Reimbursement Scenario

7.5.2. Saudi Arabia

7.5.2.1. Saudi Arabia Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.2.2. Market Dynamics

7.5.2.3. Competitive Landscape

7.5.2.4. Regulatory Framework

7.5.2.5. Reimbursement Scenario

7.5.3. UAE

7.5.3.1. UAE Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.3.2. Market Dynamics

7.5.3.3. Competitive Landscape

7.5.3.4. Regulatory Framework

7.5.3.5. Reimbursement Scenario

7.5.4. Kuwait

7.5.4.1. Kuwait Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.4.2. Market Dynamics

7.5.4.3. Competitive Landscape

7.5.4.4. Regulatory Framework

7.5.4.5. Reimbursement Scenario

7.5.5. Rest of Middle East and Africa

7.5.5.1. Rest of MEA Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.5.2. Market Dynamics

7.5.5.3. Competitive Landscape

7.5.5.4. Regulatory Framework

7.5.5.5. Reimbursement Scenario

8. Competitive Landscape

8.1. Company Market Share Analysis, 2025

8.2. Company Tier Structure

8.3. List of Major Suppliers, By Key Countries

8.4. Key Company Positioning Analysis

8.5. Company Profile

8.5.1. Abbott Laboratories

8.5.2. Acandis GmbH

8.5.3. ASAHI INTECC Co., Ltd.

8.5.4. Balt Group

8.5.5. B. Braun SE

8.5.6. Boston Scientific Corporation

8.5.7. Integer Holdings Corporation

8.5.8. Johnson & Johnson (Cerenovus)

8.5.9. Kaneka Corporation

8.5.10. Medtronic plc

8.5.11. MicroPort Scientific Corporation

8.5.12. MicroVention, Inc. (Terumo Group)

8.5.13. Penumbra, Inc.

8.5.14. Perflow Medical Ltd.

8.5.15. Rapid Medical

8.5.16. Stryker Corporation

8.5.17. Terumo Corporation

8.6. Key Development Strategies

8.6.1. New Product Launches

8.6.2. Mergers and Acquisition

8.6.3. Partnerships and Collaborations

8.6.4. Expansion Plans

9. Analyst Perspective

10. Related Reports

Related Research

Global Urinary Catheters Market Size, Share, and Industry Analysis – by Product Type, by Material Type, by Coating, by Application, by Gender, and by End-use- Growth and Trend Forecast, 2026- 2035

April 3, 2026View

Global Nasal Cannula Market Size, Share, and Industry Analysis – by Product Type, by Material Type, and by End-use – Growth and Trend Forecast, 2026- 2035

April 2, 2026View

Global Midline Catheter Market Size, Share, and Industry Analysis – by Design Type, by Material Type, by Application, and by End-use- Growth and Trend Forecast, 2026- 2035

April 2, 2026View

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.